Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children

被引:26
|
作者
Crews, Jonathan D. [1 ,3 ]
Anderson, Lauren R. [2 ]
Waller, D. Kim [3 ]
Swartz, Michael D. [3 ]
DuPont, Hebert L. [3 ,4 ]
Starke, Jeffrey R. [2 ]
机构
[1] Baylor Coll Med, Pediat Infect Dis, San Antonio, TX USA
[2] Baylor Coll Med, Pediat Infect Dis, Houston, TX 77030 USA
[3] Univ Texas Sch Publ Hlth, Houston, TX USA
[4] Baylor St Lukes Med Ctr, Houston, TX USA
关键词
TERM-CARE FACILITY; UNITED-STATES; INFECTION; EPIDEMIOLOGY; DISEASE; SURVEILLANCE; RESIDENTS; ADULTS;
D O I
10.1097/INF.0000000000000767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Clostridium difficile-associated diarrhea (CDAD) is increasingly diagnosed in children in community settings. This study aims to assess recent antibiotic use and other risk factors in children with community-associated (CA-) CDAD compared with children with other diarrheal illnesses in a tertiary care setting. Methods: Children with CA-CDAD evaluated at Texas Children's Hospital (Houston, TX) from January 1, 2012 to June 30, 2013 were identified. Two control subjects with community-associated diarrhea who tested negative for C. difficile were matched to case subjects. Data on demographics, medication exposure and outpatient healthcare encounters were collected from medical records. Multivariate logistic regression was performed to identify predictors of pediatric CA-CDAD. Results: Of 69 CA-CDAD cases, most (62.3%) had an underlying chronic medical condition and 40.6% had antibiotic exposure within 30 days of illness. However, no traditional risk factor for CDAD was identified in 23.2% and 15.9% of CA-CDAD cases within 30 and 90 days of illness onset, respectively. Outpatient healthcare encounters within 30 days were more common among CA-CDAD cases than control subjects (66.7% vs. 48.6%; P = 0.01). In the final multivariate model, CA-CDAD was associated with cephalosporin use within 30 days [odds ratio: 3.32; 95% confidence interval: 1.10-10.01] and the presence of a gastrointestinal feeding device (odds ratio: 2.59; 95% confidence interval: 1.07-6.30). Conclusions: Recent use of cephalosporins and the presence of gastrointestinal feeding devices are important risk factors for community- associated CDAD in children. Reduction in the use of outpatient antibiotics may decrease the burden of CA-CDAD in children.
引用
收藏
页码:919 / 923
页数:5
相关论文
共 50 条
  • [21] Clinical risk factors for Clostridium difficile-associated diseases
    Cho, Sung Min
    Lee, Jae Joon
    Yoon, Hee Jung
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : 256 - 261
  • [22] An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment
    Thabit, Abrar K. K.
    Aljedaani, Huda J. J.
    Alghamdi, Rawan H. H.
    Badahdah, Raghad M. M.
    Lashkar, Manar O. O.
    Alnajjar, Abeer
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (08) : 805 - 810
  • [23] Morbidity and mortality in severely burned children with Clostridium difficile-associated diarrhea
    Finnerty, Celeste C.
    Herndon, David N.
    Lee, Jong O.
    Rodriguez, Noe A.
    Al-Haj, Iman H.
    Wurzer, Paul
    Calhoun, Brendan R.
    Jeschke, Marc G.
    SURGERY, 2016, 159 (06) : 1631 - 1637
  • [24] Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization
    Lin, Hsiao-Ju
    Hung, Yuan-Pin
    Liu, Hsiu-Chuan
    Lee, Jen-Chieh
    Lee, Chih-I
    Wu, Yi-Hui
    Tsai, Pei-Jane
    Ko, Wen-Chien
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (02) : 183 - 189
  • [25] Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review
    Bloomfield L.E.
    Riley T.V.
    Infectious Diseases and Therapy, 2016, 5 (3) : 231 - 251
  • [26] The Prognostic Value of Inflammatory Markers in Clostridium difficile-associated Diarrhea
    Nseir, William
    Khamisy-farah, Rola
    Amara, Amir
    Farah, Raymond
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (10): : 658 - 661
  • [27] Risk Factors for and Estimated Incidence of Community-associated Clostridium difficile Infection, North Carolina, USA
    Kutty, Preeta K.
    Woods, Christopher W.
    Sena, Arlene C.
    Benoit, Stephen R.
    Naggie, Susanna
    Frederick, Joyce
    Evans, Sharon
    Engel, Jeffery
    McDonald, L. Clifford
    EMERGING INFECTIOUS DISEASES, 2010, 16 (02) : 197 - 204
  • [28] Epidemiology and risk factors for Clostridium difficile-associated diarrhea in adult inpatients in a university hospital in China
    Tang, Chenjie
    Li, Yang
    Liu, Chengcheng
    Sun, Pengfei
    Huang, Xu
    Xia, Wenying
    Qian, Huimin
    Cui, Lunbiao
    Liu, Genyan
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (03) : 285 - 290
  • [29] Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
    Cornely, Oliver A.
    Miller, Mark A.
    Fantin, Bruno
    Mullane, Kathleen
    Kean, Yin
    Gorbach, Sherwood
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2493 - +
  • [30] Do Probiotics Prevent Clostridium difficile-Associated Diarrhea?
    Al Sharaby, Afrah
    Abugoukh, Tahani M.
    Ahmed, Wefag
    Ahmed, Samah
    Elshaikh, Abeer O.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)